//Marketo Code //JavaScript goes here

Rule 21 CFR part 11—Electronic Discovery The US Food and Drug Administration (FDA) introduced 21 CFR part 11, entitled “Electronic Records; Electronic Signatures,” in 1997. The rule determines the requirements of computerized systems that need to be fulfilled in order to permit electronic signatures and electronic records in lieu of traditional paper-based records and hand-written signatures.